Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems.
Childhood Cancer, Childhood Hematological Disease
About this trial
This is an interventional basic science trial for Childhood Cancer focused on measuring Male fertility preservation, Testicular tissue biopsy, Male fertility status, Tanner stage, Testicular volume, Hormones, Semen analysis
Eligibility Criteria
Inclusion Criteria:
- Young adults (≥18 years).
- Diagnosis of cancer or hematological disorder during childhood (<18 years).
- High-risk gonadotoxic treatment (with an ≥80% risk of later fertility problems) during childhood.
- At least one year after the last received gonadotoxic treatment.
- Did or did not undergo a testicular tissue biopsy procedure at a young age as a fertility preservation strategy.
Exclusion Criteria:
- Prepubertal patients and adolescents (<18 years).
Sites / Locations
- Universitair Ziekenhuis Brussel
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Biopsy group
No biopsy group
Control group
Young adults (≥18 years) cured of childhood cancer or hematological disorders for which they received high-risk gonadotoxic treatment (with an ≥80% risk of later fertility problems) during childhood and who have chosen to undergo a testicular tissue biopsy procedure at a young age as a fertility preservation strategy.
Young adults (≥18 years) cured of childhood cancer or hematological disorders for which they received high-risk gonadotoxic treatment (with an ≥80% risk of later fertility problems) during childhood and who have refused to undergo a testicular tissue biopsy procedure at a young age as a fertility preservation strategy.
Spontaneously conceived young adults whose data on reproductive health have already been published (Belva F et al., 2016/2017/2019).